The Effects of pegylated interferon alpha-2a and alpha-2b therapy on chromosomal aberrations and mitotic index in patients with chronic hepatitis B Kronik Hepatit B'li Hastalarda Pegile-İnterferon Alfa-2a ve Alfa-2b'nin Kromozomal Düzensizlikler ve Mitotik İndeks Üzerine Etkileri


Akbaş H., Yalçin K., Isi H., Şimșek S., ATAY A. E., Budak T.

Turkiye Klinikleri Journal of Medical Sciences, cilt.32, sa.6, ss.1554-1559, 2012 (Scopus)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 32 Sayı: 6
  • Basım Tarihi: 2012
  • Doi Numarası: 10.5336/medsci.2011-26395
  • Dergi Adı: Turkiye Klinikleri Journal of Medical Sciences
  • Derginin Tarandığı İndeksler: Scopus
  • Sayfa Sayıları: ss.1554-1559
  • Anahtar Kelimeler: Hepatitis B, interferon alfa-2a, interferon alfa-2b, chromosome aberrations, mitotic index
  • Sağlık Bilimleri Üniversitesi Adresli: Evet

Özet

We aimed to prospectively evaluate the effects of pegylated interferon alpha-2a and alpha-2b therapy on chromosomal aberrations and mitotic index in patients with chronic hepatitis B. Material and Methods: Fifty patients with chronic hepatitis B who underwent pegylated interferon alpha-2a or 2b therapy were evaluated for chromosomal aberrations and mitotic index before the treatment and at the end of 6 months of therapy. Results: Cytogenetic examinations revealed out that there was no significant difference between pre- and post-treatment frequencies of mitotic index and chromosomal aberrations. Conclusion: Interferon alpha-2a and alpha-2b therapy which is associated with common hematologic adverse effects has no significant cytogenetic effect. © 2012 by Türkiye Klinikleri.